Share
3,467 Posts.
lightbulb Created with Sketch. 115
clock Created with Sketch.
19/07/18
09:18
Share
Originally posted by Basileus
↑
Agree - I think this is going to be another pump and dump. Time and trading will answer that question today.
I have a question for all of those who were cheering this "brilliant news".
Anyway, on to my question.
I have looked through a lot of material and one question keeps coming up - why does Medcan need QBL - what's the advantage for Medcan?
I can find no commercial reason why the owners of Medcan would even consider getting into an arrangement with a subsidiary (MCL) of a company (QBL) that has been merely existing on the fringes of the spec market for 10+ years.
Can anyone please confirm whether QBL has ever generated one cent of income from anything other than share issues and cap raising programs?
Ask yourself;
If you owned Medcan why would you sell your company to MCL (QBL) if you were confident of achieving medium term success?
If you owned Medcan would you not build the base of the company (acquire licences and sell product = income) and then sell for a higher price.
Where is the advantage in selling out to MCL (QBL)?
Hmmm .....
Expand
fund married a good story, this is perfect match in ASX backdoor listing. I don't have question on this, but only concern on trading pattern. I am just a trader, not like those who call themselves LH.